SEC reporting owner
| Reporting owner CIK | 0001768417 |
|---|---|
| Issuers | 1 |
| Qualifying disclosures | 21 |
| Public purchases | 0 |
| Recent-window purchases | 0 |
| Recent-window sales | 6 |
| Last public filing | 2026-02-28 |
| Coverage | verified |
| Publicly available | Trade date | Ticker | Code | Shares | Reported value |
|---|---|---|---|---|---|
| 2026-02-27 | 2026-02-25 | GMED | S | 20,000 | Not reported |
| 2026-02-17 | 2026-02-12 | GMED | S | 10,000 | Not reported |
| 2026-01-23 | 2026-01-21 | GMED | A | 40,000 | Not reported |
| 2025-11-28 | 2025-11-25 | GMED | S | 7,500 | Not reported |
| 2025-03-28 | 2025-01-23 | GMED | A | 40,000 | Not reported |
| 2024-12-04 | 2024-12-02 | GMED | S | 2,500 | Not reported |
| 2024-11-08 | 2024-11-06 | GMED | S | 2,500 | Not reported |
| 2024-11-08 | 2024-11-06 | GMED | S | 2,500 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.